C2 A-Taper Acetabular System
FDA premarket approval P050009 · Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented
PMA numberP050009
Approval
- Applicant
- Biomet, Inc.
- Received
- March 14, 2005
- Decision date
- December 16, 2005 (APWD)
- Supplements
- 6, latest February 11, 2011
- Product code
- MRA – Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented
Approval order statement
APPROVAL FOR THE C2A-TAPER ACETABULAR SYSTEM. THE DEVICE IS INDICATED FOR USE IN PRIMARY TOTAL HIP ARTHROPLASTY IN SKELETALLY MATURE PATIENTS WITH NON-INFLAMMATORY DEGENERATIVE JOINT DISEASE SUCH AS OSTEOARTHRITIS, AVASCULAR NECROSIS, CONGENITAL HIP DYSPLASIA, AND POST-TRAUMATIC ARTHRITIS.